Loading...
Loading...
Bilateral Trade Intelligence · 0 Countries · 0 Territories · $0 Exports · $0 Imports · DGFT Verified · Updated March 2026
India is the world's largest provider of generic medicines, exporting pharmaceutical formulations worth $0 to 0 countries and 0 territories across 0 verified shipments. India also imports pharmaceutical ingredients and finished products worth $0 from 0 countries and 0 territories across 0 shipments. The United States, United Kingdom, Canada, Germany, and France are the largest bilateral trade partners. Data sourced from Indian Customs (DGFT) shipping bill records.
| # | Country | Export Value | Export Shipments | Import Value | Import Shipments | Analysis |
|---|---|---|---|---|---|---|
| Loading... | ||||||
India is the world's largest supplier of generic medicines, accounting for 20% of global generic drug exports by volume. The Indian pharmaceutical industry exports finished dosage forms, active pharmaceutical ingredients (APIs), biosimilars, and vaccines to 0 countries and 0 territories with a combined trade value of $0. The country's cost-competitive manufacturing, WHO-GMP certified facilities, and broad product portfolio make it a critical node in global pharmaceutical supply chains.
On the import side, India sources pharmaceutical ingredients, intermediates, and specialty drugs worth $0 from 0 countries and 0 territories. China is the largest source of API imports, while the United States, Germany, and Switzerland supply specialty and patented formulations. This bilateral trade data covers 0 verified shipments from Indian Customs (DGFT) records.
Each country page provides detailed trade corridor analysis including top Indian exporters and suppliers, buyer profiles in the destination market, product formulation breakdowns, port-of-origin analysis, freight mode distribution, and AI-powered market intelligence. Use this directory to identify trade opportunities, benchmark supplier performance, and understand India's pharmaceutical trade relationships across global markets.
India exports pharmaceutical products to 0 countries and 0 territories worldwide, with a total export value of $0 across 0 shipments. The United States is the largest destination, followed by the United Kingdom, Canada, and France.
India imports pharmaceuticals worth $0 from 0 countries and 0 territories across 0 shipments. Major sources include the United States, Germany, China, Italy, and France — primarily APIs, intermediates, and specialty drugs.
All data is sourced from Indian Customs (DGFT) shipping bill records — verified export and import declarations filed with the Directorate General of Foreign Trade. TransData Nexus processes and structures this data for trade intelligence and market analysis.